5Thomas unger, MDkiel, Germany. Neurohormonal modulation in cardiovascular disease [ J ]. Am HEART J, 2000, 139: 2.
6Mackenzie HS,Troy JL,Rennke HG,et al. TCV116 prevents progressive renal injury in rats with extensive renal mass ablation[J] .J Hypertens,1994, 12(supp 9): 11.
7Muller P,Flesch G,De Gasparo M,et al. Pharmacokinetics and pharmacodynamic effects of the angiotensit Ⅱ antagonist valsartan at steady state in healthy,normotensive subjects[J] .Eur J Clin Phermacol, 1997,52:441.
8Goldberz Ai, Dunlay MC, Sweet CS .Saftery and tolerability of losarran potassium. An angiotensin Ⅱ receptor antegemist,compared with HCTZ,atenolol, felodipine ER,and angio conversing enzyme inhibitors for the treatment of systemic hypertension[J] .Am J Cardiol, 1995,75: 793.
9陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
10Loeffler L F,Navas-Acien A,Brady T M,et al.Uric acid level and elevated blood pressure in US adolescents:National Health and Nutrition Examination Survey,1999-2006[J].Hypertension,2012,59(4):811-817.
